Name | AKTSIONERNOE OBSCHESTVO "URALGIDROMED'" |
---|
INN | 6626002037 |
---|
KPP | 667901001 |
---|
OGRN | 1026601606206 |
---|
OKPO | 32258295 |
---|
FFSM | 31173-D |
---|
Address | 623391, Sverdlovskaya Oblast', g Polevskoy, r-n Zapadnyy Promyshlennyy, d. ZD. 2/2 |
---|
Phone | +7 (343) 504-00-88 Contact details |
|
OKVED code | Type | Name of activity type |
---|
71.12.3 | Core activity | Exploration work, geophysical and geochemical study in the field of mineral resources and the reproduction of the mineral resource base | 07.29.1 | Additional activity | Mining and processing of copper ore | 24.41 | Additional activity | Production and primary processing of precious metals | All types of activities | 24.43 | Additional activity | Production of lead, zinc and tin | 24.44 | Additional activity | copper production | 24.45 | Additional activity | Manufacture of other non-ferrous metals | 43.13 | Additional activity | exploratory drilling | 46.19 | Additional activity | Activity of agents in wholesale trade of universal assortment of goods | 46.72.2 | Additional activity | Wholesale trade of ores, metals and metal stuff | 46.72.23 | Additional activity | Wholesale trade of ores, metals and metal stuff 4661 | 72.19 | Additional activity | Research and experimental development on natural sciences and engineering Other |
Registration date | 15.08.2002 |
---|
Registering department | Administratsiya goroda Polevskogo |
---|
|
AO "URALGIDROMED'" (Sverdlovsk Oblast; INN 6626002037) was registered on 15 Aug 2002. The company's authorized capital as of July 1, 2012 was 141970500 rub. Type of ownership of AO "URALGIDROMED'" - Open joint-stock companies. Form of ownership of AO "URALGIDROMED'" - Combined municipal and foreign property. Principal activities of AO "URALGIDROMED'": exploration work, geophysical and geochemical study in the field of mineral resources and the reproduction of the mineral resource base (71.12.3), mining and processing of copper ore (07.29.1), production and primary processing of precious metals (24.41). |
Economic indicators2021
Net profit (RAS) of AO URALGIDROMED' made up 302.91 million RUB over 2021 compared to net loss of 1.99 million RUB over 2020, the company informed. Revenue increased in the accounting period 1.51 times to 1.29 billion RUB from 851.97 million RUB over 2020; cost of goods sold grew by 9.28% to 782.71 million RUB from 716.26 million RUB; sales profit went up 11.06 times to 398.35 million RUB from 36.02 million RUB. 2020
Net loss (RAS) of AO URALGIDROMED' dropped over 2020 53.24 times to 1.99 million RUB from 105.78 million RUB KAgent.Entities.Balance, the company informed. Revenue increased in the accounting period by 5.32% to 851.97 million RUB from 808.91 million RUB over 2019; cost of goods sold decreased by 2.67% to 716.26 million RUB from 735.90 million RUB; sales profit made up 36.02 million RUB compared to sales loss of 94.83 million RUB. 2019
Net loss (RAS) of AO URALGIDROMED' increased 1.77 times to 105.78 million RUB from 59.83 million RUB over 2018, the company informed. Revenue decreased in the accounting period by 0.60% to 808.91 million RUB from 813.82 million RUB in 2018; cost of goods sold grew by 2.63% to 735.90 million RUB from 717.06 million RUB; sales loss made up 94.83 million RUB compared to sales profit of 2.39 million RUB. 2018
Net loss (RAS) of AO URALGIDROMED' dropped over 2018 by 32.13% to 59.83 million RUB from 88.16 million RUB KAgent.Entities.Balance, the company informed. Revenue increased in the accounting period by 14.90% to 813.82 million RUB from 708.32 million RUB over 2017; cost of goods sold grew by 3.79% to 717.06 million RUB from 690.85 million RUB; sales profit made up 2.39 million RUB compared to sales loss of 69.72 million RUB. 2017
Net loss (RAS) of AO URALGIDROMED' over 2017 was the same as in 2016 reaching 88.16 million RUB, the company informed. Revenue decreased in the accounting period by 13.05% to 708.32 million RUB from 814.62 million RUB in 2016; cost of goods sold decreased by 10.68% to 690.85 million RUB from 773.42 million RUB; sales loss grew 1.78 times to 69.72 million RUB from 39.23 million RUB. 2016
Net loss (RAS) of URALGIDROMED', OAO increased 5.45 times to 88.28 million RUB from 16.21 million RUB over 2015, the company informed. Revenue increased in the accounting period by 47.08% to 814.62 million RUB from 553.86 million RUB over 2015; cost of goods sold grew 1.86 times to 773.42 million RUB from 415.52 million RUB; sales loss made up 39.23 million RUB compared to sales profit of 53.28 million RUB. 2014
Net loss (RA) of URALGIDROMED', OAO made up 107.04 million RUB over 2014 compared to net profit of 25.94 million RUB over 2013, the company informed. Revenue decreased in the accounting period by 7.98% to 371.35 million RUB from 403.55 million RUB in 2013; cost of goods sold decreased by 9.09% to 285.91 million RUB from 314.49 million RUB; sales profit fell 3.69 times to 12.11 million RUB from 44.68 million RUB. 2013
Net profit (RAS) of URALGIDROMED, OAO dropped in 2013 by 43.50% to 25.94 million RUB from 45.91 million RUB over the same period in 2012, the company informed. Revenue decreased in the accounting period by 16.07% to 403.55 million RUB from 480.82 million RUB in 2012; cost of goods sold decreased by 13.24% to 314.49 million RUB from 362.48 million RUB; sales profit fell by 36.09% to 44.68 million RUB from 69.90 million RUB. 2012
Net profit (RAS) of Uralgidromed, OAO dropped in 2012 3.56 times to 45.91 million RUB from 163.37 million RUB over the same period in 2011, the company informed. Cost of goods sold decreased by 13.01% to 362.48 million RUB from 416.68 million RUB; sales profit fell 3.66 times to 69.90 million RUB from 255.95 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|